Tracking Origins of Prostate Cancer: An Innovative in Vivo Modeling
Final rept. 1 Sep 2010-31 Aug 2014
WAKE FOREST UNIV WINSTON-SALEM NC
Pagination or Media Count:
Heterogeneity, variable and often unpredictable clinical course are fundamental challenges in management of patients with prostate cancer. To make rapid advances in understanding of disease mechanism that can be translated to clinical care in short order, there is an immediate need for innovative in vivo disease models that accurately recapitulate human disease at cellular level. We propose to develop an innovative and hitherto not attempted in vivo prostate cancer model that will delineate the exact cell of origin through different stages of prostate cancer development and progression. We propose to study possible cells of origin for prostate cancer by combinatorial expression of florescent magenta, cyan and yellow primary color proteins in prostate at development in mice. The study includes 1 Construction of Prorainbow plasmid with fluorescent proteins XFPs under control by prostate epithelial and basal cell-specific promoters. 2Establish mouse line with the resulting Prorainbow construct and generation of transgenic mice by crossing with Cre mice. 3 Study the transgenic Prorainbow mice under normal and oncogenic conditions. The study is expected to produce in vivo animal of prostate cancer with unique capabilities.
- Medicine and Medical Research